develop
highthroughput
dna
sequenc
technolog
enabl
largescal
character
function
antibodi
repertoir
new
method
understand
protect
pathogen
immun
respons
import
paramet
consid
sequenc
antibodi
repertoir
includ
methodolog
bcell
popul
clinic
characterist
individu
analys
bioinformat
analysi
although
focus
sequenc
immunoglobulin
heavi
chain
complement
determin
region
util
monitor
particular
immun
respons
bcell
malign
highfidel
analysi
fulllength
pair
heavi
light
chain
express
individu
b
cell
critic
character
function
antibodi
repertoir
bioinformat
identif
clonal
antibodi
famili
recombin
express
repres
member
produc
recombin
antibodi
use
identifi
antigen
target
function
immun
respons
investig
mechan
protect
pathogen
function
integr
analysi
coexpress
function
gene
provid
potenti
pinpoint
import
antibodi
clonal
famili
gener
immun
respons
sequenc
antibodi
repertoir
transform
understand
immun
respons
autoimmun
vaccin
infect
cancer
anticip
antibodi
repertoir
sequenc
provid
nextgener
biomark
diagnost
tool
therapeut
antibodi
spectrum
diseas
includ
rheumat
diseas
antibodi
major
compon
adapt
immun
system
critic
role
protect
pathogen
immun
respons
respons
microbi
infect
vaccin
autoimmun
diseas
cancer
immun
system
gener
distinct
antibodi
repertoir
analysi
antibodi
repertoir
particularli
contribut
function
immun
respons
provid
import
inform
protect
pathogen
immun
autoimmun
diseas
includ
autoimmun
rheumat
diseas
antibodi
character
enabl
identif
autoantigen
provid
insight
underli
mechan
diseas
furthermor
detect
autoantibodi
becom
cornerston
modern
diagnost
infecti
diseas
antibodi
respons
usual
protect
grow
interest
isol
antibodi
could
develop
novel
therapeut
agent
use
microbi
antigen
epitop
target
antibodi
respons
develop
vaccin
challeng
understand
well
diagnost
therapeut
har
antibodi
respons
identif
antibodi
underli
function
immun
respons
antibodi
directli
contribut
immun
outcom
neutral
microbi
pathogen
mediat
autoimmun
tissu
injuri
review
provid
overview
technolog
largescal
sequenc
antibodi
repertoir
discuss
technolog
appli
character
immun
respons
identifi
antibodi
therapeut
diagnost
mechanist
relev
autoimmun
diseas
includ
rheumat
diseas
antibodi
compris
immunoglobulin
heavi
chain
igh
light
chain
igl
contain
antigenbind
domain
gener
recombin
junction
diversif
somat
hypermut
variabl
v
join
j
andor
divers
gene
segment
bcell
develop
complementaritydetermin
region
cdr
well
surround
framework
region
togeth
form
antigenbind
site
antibodi
primari
bcell
repertoir
substanti
divers
antibodi
specif
come
igh
owe
gener
combinatori
gene
segment
nregion
divers
ongo
immun
respons
antigen
b
cell
produc
antibodi
specif
antigen
diversifi
undergo
clonal
expans
somat
hypermut
antibodi
variabl
region
process
term
affin
matur
b
cell
express
antibodi
increas
affin
activ
antigen
result
somat
hypermut
select
expans
figur
antigenactiv
affinitymatur
b
cell
releas
germin
center
blood
shortliv
longliv
plasmablast
migrat
secondari
lymphoid
organ
site
tissu
injuri
differenti
longliv
memori
b
cell
plasma
cell
identifi
antigen
diseas
knowledg
antigen
epitop
target
antibodi
respons
limit
exampl
autoimmun
diseas
affect
global
popul
yet
diseas
pathogen
autoantigen
identifi
infecti
diseas
critic
microbi
antigen
epitop
target
protect
antibodi
respons
also
unidentifi
except
hiv
antigen
influenza
microb
regard
cancer
tcellmedi
respons
still
consid
primari
form
immun
although
immunotherapi
revolution
cancer
therapi
specif
target
immun
respons
therapi
unclear
contribut
antibodi
respons
effect
anticanc
immun
varieti
array
display
approach
develop
investig
antibodi
respons
includ
protein
peptid
array
aptam
peptoid
array
random
peptid
array
largescal
peptid
array
human
protein
array
human
proteom
display
array
one
major
challeng
approach
use
serum
plasma
sampl
sourc
antibodi
analys
serum
plasma
sampl
contain
pool
antibodi
produc
individu
includ
antibodi
heterogen
bind
mani
differ
antigen
differ
affin
avid
therebi
increas
background
reactiv
dilut
potenti
antibodi
interest
furthermor
serum
antibodi
produc
plasma
cell
gener
prior
immun
respons
produc
plasmablast
plasma
cell
respond
immunogen
antigen
interest
anoth
major
challeng
approach
involv
screen
bind
blood
antibodi
panel
preselect
antigen
exampl
import
autoantigen
rheumatoid
arthriti
ra
posttransl
citrullin
system
lupu
erythematosu
sle
posttransl
cleav
phosphoryl
therefor
preselect
antigen
might
result
failur
detect
pathogen
autoantibodi
clonal
famili
antigenagnost
approach
box
therefor
need
identifi
import
function
antibodi
target
ideal
solut
isol
recombinantli
express
character
antibodi
produc
specif
subset
b
cell
particip
function
immun
respons
vaccin
infect
cancer
diseas
human
anim
review
describ
sever
dna
sequenc
approach
current
use
achiev
end
select
bcell
popul
import
consider
antibodi
sequenc
best
b
cell
character
function
antibodi
repertoir
includ
plasmablast
plasma
cell
memori
b
cell
tissueinfiltr
b
cell
figur
cell
plasmablast
memori
b
cell
two
popul
present
peripher
blood
therefor
easili
isol
human
plasmablast
plasma
cellsplasmablast
plasma
cell
antibodyproduc
cell
immun
system
immun
respons
plasmablast
differenti
antigenactiv
b
cell
releas
germin
center
transient
circul
bloodstream
migrat
secondari
lymphoid
organ
inflam
tissu
differenti
longerliv
tissueresid
plasma
cell
plasmablast
peripher
blood
form
newli
gener
naiv
b
cell
also
reactiv
memori
b
cell
togeth
rel
eas
isol
plasmablast
origin
either
naiv
memori
b
cell
make
ideal
bcell
popul
analys
search
antibodi
associ
given
immun
respons
exampl
studi
sequenc
antibodi
respons
influenza
vaccin
detect
transient
increas
peripher
blood
plasmablast
number
produc
antiinfluenza
antibodi
although
autoimmun
diseas
chronic
evid
exist
underli
autoantibodi
respons
involv
continu
activ
reactiv
new
bcell
clone
peripher
blood
plasmablast
could
produc
new
pathogen
antibodi
stage
diseas
inde
patient
ra
proport
plasmablast
blood
correl
posit
diseas
activ
cell
produc
anticitrullin
protein
antibodi
acpa
known
contribut
patholog
ra
tissueresid
plasma
cell
might
also
produc
acpa
might
even
gener
situ
synovi
tissu
patient
ra
howev
tissueresid
cell
easili
access
memori
b
cellsmemori
b
cell
form
germin
centr
reaction
provid
acceler
antibodi
respons
upon
reexposur
target
antigen
wherea
peripher
blood
plasmablast
specif
antigen
target
ongo
immun
respons
antigenspecif
memori
b
cell
present
much
lower
frequenc
approxim
memori
b
cell
blood
specif
incit
antigen
memori
b
cell
isol
antigensort
fluorescenceactiv
cell
sort
fac
fluorescentlylabel
antigen
bait
sort
cell
specif
membran
immunoglobulin
memori
b
cell
peripher
blood
howev
low
frequenc
antigenspecif
memori
b
cell
sort
requir
larg
number
peripher
blood
mononuclear
cell
substanti
differ
antigen
load
prior
exposur
histori
rout
exposur
associ
immunostimulatori
molecul
differ
vaccin
microbi
infect
autoimmun
diseas
influenc
magnitud
properti
antibodi
respons
modif
antibodi
repertoir
sequenc
method
might
need
effect
character
antibodi
respons
condit
tissueinfiltr
b
cellsanalysi
tissueinfiltr
b
cell
could
also
help
character
function
antibodi
respons
despit
difficult
access
peripher
blood
b
cell
character
tissueinfiltr
b
cell
autoimmun
diseas
cancer
identifi
diseaseassoci
antibodi
integr
analysi
bcell
antibodi
repertoir
synovium
blood
patient
ra
brain
blood
patient
multipl
sclerosi
provid
insight
site
bcell
activ
affin
matur
diseas
approach
use
analysi
antibodi
repertoir
involv
revers
transcriptas
polymeras
chain
reaction
rtpcr
sanger
sequenc
antibodi
express
individu
b
cell
experiment
step
techniqu
requir
manual
handl
practic
approach
character
ten
hundr
b
cell
per
experi
despit
low
throughput
techniqu
use
identifi
antibodi
neutral
clinic
import
pathogen
influenza
virus
autoantibodi
contribut
autoimmun
diseas
varieti
approach
use
singlecel
rna
sequenc
sever
enabl
sequenc
coexpress
gene
use
nextgener
technolog
howev
assay
platform
shortread
sequenc
technolog
exampl
platform
illumina
usa
read
consider
fewer
base
pair
necessari
sequenc
entir
igl
igh
variabl
region
varieti
highthroughput
nextgener
sequenc
technolog
develop
transform
analysi
b
cell
antibodi
repertoir
technolog
appli
varieti
way
import
paramet
character
function
antibodi
respons
includ
methodolog
approach
bcell
popul
character
clinic
characterist
individu
analys
approach
bioinformat
analysi
object
experi
monitor
specif
b
cellsa
number
research
group
develop
approach
deepsequenc
igh
case
igl
sole
genom
dna
cdna
gener
bulk
rna
isol
individu
autoimmun
diseas
infect
cancer
vaccin
recipi
instanc
molecular
barcod
use
enhanc
singlechain
sequenc
random
hexam
use
primer
adapt
uniqu
molecular
identifi
tag
cdna
molecular
barcod
enabl
correct
basecal
error
inher
sequenc
platform
pcr
bia
although
correct
rtpcr
error
accur
identif
clonal
proport
b
cell
pool
sequenc
immunoglobulin
gene
genom
dna
challeng
mani
b
cell
multipl
rearrang
immunoglobulin
gene
loci
result
nonproduct
rearrang
receptor
edit
furthermor
receptor
edit
import
featur
bcell
matur
help
prevent
autoimmun
lead
allel
inclus
immunoglobulin
igl
loci
develop
b
cell
coexpress
two
differ
immunoglobulin
igl
therebi
confound
sequenc
igh
igl
cdna
individu
b
cell
moreov
although
rapid
method
usual
involv
sequenc
one
immunoglobulin
chain
therefor
provid
limit
inform
antibodi
gener
immun
respons
although
igh
igl
sequenc
simultan
bulk
mrna
pair
igh
igl
sequenc
obtain
way
attempt
accord
similar
sequenc
frequenc
pair
alway
accur
without
accur
pair
cognat
igh
igl
inform
gener
antibodi
respons
incomplet
although
optim
analysi
antibodi
repertoir
singlechain
sequenc
bulk
rna
use
track
malign
clonal
popul
b
cell
detect
uniqu
igh
igl
sequenc
method
prove
power
detect
monitor
recurr
bcell
malign
better
sensit
detect
residu
diseas
diseas
recurr
flow
cytometri
convent
approach
igh
sequenc
also
use
search
biomark
autoimmun
diseas
character
bcell
respons
infect
vaccin
immunomodul
patient
cancer
result
bulk
igh
sequenc
unsort
b
cell
suggest
direct
analysi
isol
bcell
subset
might
necessari
obtain
inform
data
regard
diseas
immun
function
addit
data
need
assess
whether
sequenc
singl
chain
singlechain
provid
biomark
clinic
util
function
antibodi
repertoiremani
challeng
must
overcom
understand
identifi
function
antibodi
repertoir
tabl
addit
high
throughput
analysi
comprehens
survey
bcell
repertoir
requir
sequenc
enabl
accur
recreat
endogen
bioinformat
select
antibodi
antigen
specif
bind
function
properti
character
accur
recreat
recombin
version
endogen
antibodi
one
must
sequenc
correctli
pair
cognat
igh
igl
express
individu
b
cell
ensur
sequenc
cover
entir
variabl
region
encod
framework
region
igh
igl
ensur
sequenc
errorfre
highprocess
fidel
qualiti
major
challeng
robust
analysi
antibodi
repertoir
discuss
articl
furthermor
enabl
bioinformat
identif
import
function
antibodi
antibodi
repertoir
sequenc
must
appli
appropri
bcell
subset
deriv
individu
immunolog
phenotyp
interest
tabl
sever
new
singlecel
sequenc
method
preserv
endogen
pair
igh
igl
figur
method
includ
linkagepcr
base
barcodebas
beadbas
microwellbas
dropletbas
method
approach
integr
one
method
linkagepcra
method
physic
link
therebi
sequenc
igh
igl
pair
individu
b
cell
overlapextens
also
known
linkag
pcr
sever
group
adapt
techniqu
highthroughput
sequenc
igh
igl
pair
one
method
involv
deposit
singl
b
cell
highdens
microwel
plate
captur
mrna
oligodt
bead
use
emulsionbas
linkag
pcr
physic
link
amplifi
igh
igl
pair
sequenc
region
figur
integr
longread
sequenc
technolog
cell
barcod
univers
prime
linkagepcrbas
approach
yield
robust
antibodi
repertoir
dataset
cell
barcodingin
laboratori
develop
cellbarcod
method
antibodi
repertoir
sequenc
approach
cdna
gener
individu
b
cell
label
uniqu
cell
barcod
use
univers
adapt
figur
figur
ad
via
templateswitch
activ
revers
transcriptas
enabl
fulllength
unbias
sequenc
antibodi
variabl
region
b
cell
multipl
copi
mrna
encod
igh
igl
gene
cell
barcod
creat
consensu
igh
igl
sequenc
cell
therebi
enabl
correct
error
inher
sequenc
platform
also
aris
rtpcr
figur
furthermor
cellbarcod
enabl
accur
calcul
bcell
clonal
proport
figur
provid
errorcorrect
sequenc
fulllength
v
region
nativ
pair
igh
igl
enabl
direct
gene
synthesi
variabl
region
antibodi
recombin
express
approach
use
understand
human
plasmablast
antibodi
respons
ra
staphylococcu
aureu
infect
influenza
vaccin
bioinformat
analysi
sequenc
dataset
lead
develop
phylogenet
tree
guid
select
recombin
express
plasmablast
antibodi
includ
acpa
implic
pathogenesi
ra
antibodi
mediat
opsonophagocytosi
staphylococcu
aureu
neutral
influenza
method
rapid
comprehens
character
antibodi
respons
possibl
gener
affinitymatur
monoclon
human
antibodi
high
effici
rel
hybridoma
classic
approach
gener
monoclon
antibodi
wardemann
colleagu
develop
barcod
primer
matrix
pcr
util
distinct
set
barcod
vgene
forward
primer
barcod
constantregion
revers
pcr
primer
multiplex
cellbas
barcod
singlecellsort
b
cell
figur
droplet
pcrsever
group
work
develop
dropletbas
approach
util
bead
linkagepcr
barcod
enabl
sequenc
igh
igl
pair
express
individu
b
cell
figur
techniqu
offer
potenti
increas
throughput
analysi
reduc
cost
furthermor
droplet
pcr
also
term
digit
pcr
isol
amplifi
individu
dna
molecul
emuls
droplet
therebi
reduc
pcr
bia
sampl
depthan
import
requir
nextgener
singlecel
sequenc
technolog
gener
dataset
igh
igl
pair
suffici
number
b
cell
enabl
bioinformat
gener
phylogenet
tree
identif
clonal
antibodi
famili
sampl
depth
necessari
character
function
antibodi
respons
depend
popul
b
cell
analys
exampl
antigenspecif
memori
b
cell
present
blood
frequenc
cell
therefor
rel
larg
number
cell
must
obtain
blood
case
leukapharesi
isol
memori
b
cell
specif
antigen
specif
identifi
clonal
famili
memori
b
cell
contrast
plasmablast
produc
activ
antibodi
respons
extens
redund
clonal
famili
number
group
calcul
peripher
blood
plasmablast
express
antibodi
specif
antigen
target
ongo
immun
respons
result
sequenc
plasmablast
antibodi
repertoir
individu
function
immun
respons
analysi
hundr
thousand
plasmablast
obtain
littl
ml
blood
ml
infant
suffici
robustli
identifi
character
clonal
famili
bioinformat
methodsa
number
bioinformat
method
develop
v
j
gene
assign
antibodi
repertoir
analysi
clonal
famili
defin
b
cell
share
igh
vj
igl
vj
usag
stricter
definit
clonal
famili
igh
vj
igl
vj
must
ident
length
amino
acid
sequenc
must
certain
degre
homolog
suggest
b
cell
express
antibodi
aros
b
cell
progenitor
clonal
famili
gener
expans
common
progenitor
b
cell
independ
de
novo
recombin
event
converg
evolut
bcell
respons
accumul
mutat
b
cell
express
igh
v
j
igl
vj
differ
genom
origin
result
converg
encod
antibodi
sequenc
regardless
particular
ontolog
clonal
famili
defin
gener
b
cell
common
progenitor
select
expand
ongo
immun
respons
word
b
cell
express
highaffin
antibodi
enabl
outcompet
b
cell
germin
centr
antigen
growth
factor
affin
matur
furthermor
crosspati
analysi
antibodi
repertoir
individu
common
immun
phenotyp
proven
power
method
identifi
share
igh
v
j
igl
vj
encod
antibodi
function
activ
increas
frequenc
compar
identif
clonal
famili
alon
import
direct
antibodi
repertoir
sequenc
integr
analysi
coexpress
gene
approach
analog
simultan
sequenc
tcell
receptor
function
gene
demarc
tcell
subset
investig
laboratori
simultan
sequenc
igh
igl
gene
along
set
function
bcell
subset
gene
figur
strategi
integr
inform
function
bcell
subset
antibodi
repertoir
data
therebi
enhanc
abil
identifi
function
antibodi
b
cell
coexpress
function
gene
includ
transcript
factor
effector
molecul
indic
differenti
plasma
cell
memori
b
cell
longliv
plasmablast
matur
bcell
subset
quantit
analysi
coexpress
function
gene
indic
distinct
function
bcell
tcell
subset
cellular
molecular
barcod
need
measur
express
code
mrna
cell
obtain
largescal
highfidel
highqual
sequenc
data
critic
challeng
sequenc
antibodi
repertoir
essenti
biomark
analysi
gener
diagnost
therapeut
antibodi
achiev
end
accur
determin
bcell
clonal
proport
need
error
correct
provis
highfidel
sequenc
comprehens
analysi
variabl
region
express
chosen
bcell
subset
captur
entir
repertoir
abil
detect
pcr
contamin
tabl
analysi
clonal
proportionsaccur
measur
size
clonal
famili
import
estim
degre
immun
system
select
expand
b
cell
express
particular
antibodi
select
immun
system
indic
high
affin
bcell
membran
immunoglobulin
cognat
antigen
therebi
outcompet
b
cell
antigen
growth
factor
germin
centr
figur
studi
antibodi
respons
influenza
vaccin
cellbarcod
approach
figur
investig
laboratori
found
larg
clonal
famili
encod
antibodi
bind
influenza
hemagglutinin
higher
affin
certain
case
effect
neutral
influenza
viru
antibodi
part
larg
clonal
famili
pcr
bia
certain
templat
amplifi
effici
templat
distort
clonal
proport
addit
activ
b
cell
plasmablast
express
much
rna
memori
b
cell
rest
b
cell
absenc
cellbas
barcod
amplif
within
emuls
droplet
might
suggest
artifici
differ
clonal
proport
analysi
antibodi
express
individu
cell
cell
barcod
figur
emuls
droplet
correct
minim
pcr
bia
enabl
accur
determin
clonal
proport
biolog
variat
versu
errorrobust
analysi
dataset
highli
depend
obtain
highfidel
errorfre
sequenc
sequenc
error
aris
rtpcr
sequenc
platform
sever
group
demonstr
sequenc
dna
plasmid
encod
singl
antibodi
singl
tcell
receptor
error
nextgener
sequenc
alon
result
artefactu
identif
clonal
famili
varieti
approach
develop
error
correct
two
use
molecul
cell
barcod
cell
barcod
provid
multipl
advantag
molecular
barcod
includ
error
correct
rtpcr
basecal
sequenc
error
well
accur
assess
clonal
proport
figur
repertoir
use
vgene
primer
might
fail
amplifi
variabl
region
contain
v
gene
encod
germlin
sequenc
insuffici
homolog
acquir
somat
hypermut
residu
primer
hybrid
inde
laboratori
antibodi
repertoir
analysi
plasmablast
influenza
vaccin
recipi
found
antibodi
analys
igh
igl
variabl
region
would
amplifi
stateoftheart
vgenespecif
primer
captur
highli
mutat
antibodi
import
might
acquir
variabl
region
mutat
confer
bind
function
activ
abil
detect
pcr
contaminationmost
nextgener
sequenc
approach
antibodi
repertoir
analysi
util
pcr
amplifi
dna
isol
cdna
gener
b
cell
pcr
exponenti
amplifi
sequenc
highli
prone
contamin
amplicon
prior
experi
sequenc
isol
antibodi
repertoir
analysi
high
degre
nucleotid
sequenc
homolog
detect
pcr
contamin
difficult
cell
molecul
barcod
provid
mean
bioinformat
monitor
detect
pcr
contamin
monoclon
antibodi
mainstay
diagnost
test
therapeut
research
tool
highthroughput
sequenc
antibodi
repertoir
power
new
approach
gener
recombin
monoclon
antibodi
directli
human
anim
function
immun
respons
therapeut
monoclon
antibodi
revolution
care
patient
autoimmun
diseas
antitnf
monoclon
antibodi
infect
antirespiratori
syncyti
viru
antibodi
cancer
antiprogrammeddeath
antibodi
investig
laboratori
use
barcodeen
antibodi
repertoir
sequenc
figur
plasmablast
isol
staphylococcu
aureusinfect
human
gener
recombin
antibodi
bind
mediat
kill
bacteria
other
isol
individu
b
cell
microwel
perform
linkag
rtpcr
sequenc
figur
gener
tetanu
toxoid
tt
reactiv
recombin
antibodi
ttsort
peripher
blood
plasmablast
isol
ttvaccin
human
effect
approach
need
effect
monitor
immun
respons
health
autoimmun
microbi
infect
biothreat
detect
vaccin
cancer
monitor
immun
respons
provid
opportun
earli
diagnosi
predict
flare
monitor
remiss
assess
respons
immunomodulatori
therapi
vaccin
autoimmunityinvestig
laboratori
use
barcodeen
antibodi
repertoir
sequenc
figur
peripher
blood
plasmablast
deriv
patient
ra
identifi
sequenc
encod
autoantibodi
target
citrullin
fibrinogen
citrullin
enolas
other
use
igh
singlechain
sequenc
bulk
rna
isol
synovium
patient
ra
identifi
domin
clone
util
gene
segment
longer
antibodi
express
naiv
b
cell
sequenc
encod
pathogen
autoantibodi
potenti
use
predict
biomark
identifi
individu
like
develop
diseas
experi
autoimmun
diseas
flare
respond
immunomodulatori
therapi
lead
hypothesi
mucos
site
includ
lung
oral
caviti
might
critic
initi
acpa
respons
lead
develop
ra
antibodi
repertoir
sequenc
technolog
gener
sequenc
read
extend
suffici
far
antibodi
constant
region
identifi
antibodi
isotyp
subclass
therebi
enabl
iga
acpaexpress
b
cell
pinpoint
gain
insight
potenti
environment
exposur
microbi
infect
initi
product
ra
final
sequenc
also
potenti
use
pharmacodynam
biomark
monitor
respons
immunomodulatori
drug
expedit
clinic
develop
demonstr
activ
drug
proofofconcept
studi
vaccin
developmenta
great
need
exist
develop
vaccin
varieti
pathogen
antibodi
repertoir
sequenc
use
identifi
microbi
antigen
epitop
target
effect
antimicrobi
antibodi
respons
natur
control
infect
human
anim
therebi
enabl
develop
vaccin
base
antigen
addit
antibodi
repertoir
sequenc
use
clinic
proofofconcept
trial
demonstr
candid
vaccin
adjuv
vaccin
regimen
induc
protect
immun
respons
immunomodulatori
drug
developmentimmunomodulatori
checkpoint
inhibitor
revolution
care
patient
autoimmun
diseas
cancer
abatacept
block
activ
cell
efficaci
treatment
ra
patient
metastat
melanoma
cancer
ipilimumab
antibodi
pembrolizumab
antibodi
therapeut
effect
block
inhibit
cell
antibodi
repertoir
analysi
sequenc
provid
approach
monitor
character
immun
respons
induc
candid
immunomodulatori
drug
vaccin
checkpoint
inhibitor
therapi
cancer
result
induct
autoimmun
subset
patient
antibodi
repertoir
sequenc
potenti
use
identifi
individu
risk
develop
autoimmun
diseas
character
autoimmun
respons
individu
analys
sequenc
antibodi
repertoir
individu
compar
sequenc
correspond
germlin
antibodi
gene
lineag
develop
b
cell
evolut
antibodi
respons
track
use
analysi
one
model
investig
evolut
function
antibodi
respons
health
diseas
reveal
mechan
underli
develop
nativ
bcell
repertoir
activ
develop
traffick
b
cell
immun
respons
interest
sever
academ
laboratori
process
util
antibodi
repertoir
sequenc
investig
develop
anticitrullinatedproteinreact
b
cell
ra
antinuclearantigenreact
b
cell
sle
studi
might
identifi
autoantigen
provid
insight
diseas
initi
progress
diseas
identif
critic
antigen
epitop
target
function
antibodi
respons
need
approach
requir
prior
knowledg
target
antigen
use
screen
vast
number
hybridoma
b
cell
panel
candid
antibodi
antibodi
repertoir
sequenc
contrast
requir
knowledg
appli
plasmablast
deriv
human
anim
immun
phenotyp
interest
method
enabl
bioinformat
identif
clonal
famili
antibodi
within
function
bcell
respons
without
express
screen
antibodi
clonal
antibodi
famili
defin
import
antigen
determin
immun
respons
recombin
antibodi
gener
plasmablast
clonal
famili
use
identifi
antigen
specif
cell
antigen
discoveri
uncov
target
antibodi
also
cell
b
cell
cell
coordin
respons
macromolecular
antigen
complex
comprehens
dataset
gener
largescal
sequenc
antibodi
repertoir
combin
identif
correspond
antigen
target
import
antibodi
anticip
enabl
bioinformat
model
antibodyantigen
structurebind
relationship
ultim
lead
antibodi
variabl
region
sequenc
use
predict
antibodi
specif
effect
character
antibodi
repertoir
requir
highfidel
analysi
fulllength
igh
igl
pair
express
individu
b
cell
enabl
robust
bioinformat
analysi
repertoir
accur
recombin
gener
select
antibodi
use
identifi
target
antigen
investig
mechan
protect
pathogen
function
technolog
util
cellbarcod
analys
fulllength
pair
igh
igl
anticip
provid
greatest
util
term
identifi
biomark
gain
new
insight
pathogenesi
ra
sle
autoimmun
rheumat
diseas
diseas
antibodi
repertoir
analysi
transform
understand
immun
respons
autoimmun
vaccin
infect
cancer
provid
new
biomark
diagnost
tool
enabl
effici
gener
therapeut
antibodi
develop
highthroughput
dna
sequenc
enabl
largescal
analysi
antibodi
repertoir
respons
critic
paramet
character
function
antibodi
repertoir
includ
methodolog
bcell
popul
character
clinic
characterist
individu
analys
bioinformat
analysi
highfidel
analysi
fulllength
pair
heavi
light
chain
express
individu
b
cell
critic
character
function
antibodi
repertoir
analysi
coexpress
function
gene
identifi
antibodi
contribut
function
immun
respons
sequenc
antibodi
repertoir
transform
understand
pathogen
protect
immun
respons
autoimmun
infect
vaccin
cancer
term
antigen
agnost
mean
independ
antigen
identif
novel
autoantigen
analysi
immun
respons
antigen
agnost
fashion
import
identifi
pathogen
b
cell
cell
robinson
page
figur
bcell
respons
b
cell
undergo
clonal
expans
affin
matur
encount
antigen
tcell
help
costimulatori
signal
process
gener
occur
germin
centr
within
secondari
lymphoid
organ
affin
matur
involv
two
process
somat
hypermut
clonal
select
somat
hypermut
cytidinedeaminasemedi
process
antibodi
cdr
mutat
time
per
cell
divis
clonal
select
involv
competit
b
cell
antigen
growth
factor
germin
centr
result
b
cell
express
highestaffin
antibodi
select
expand
surviv
multipl
round
somat
hypermut
clonal
select
antibodyexpress
b
cell
produc
antibodi
increas
affin
target
antigen
b
cell
express
highaffin
antibodi
respond
growth
factor
signal
induc
differenti
plasmablast
memori
b
cell
plasmablast
transient
circul
blood
migrat
secondari
lymphoid
organ
tissu
involv
diseas
process
includ
tissu
autoimmun
infecti
malign
attack
memori
b
cell
circul
blood
enabl
rapid
recal
respons
upon
reexposur
target
antigen
wherea
plasma
cell
local
primarili
bone
marrow
lamina
propria
secret
antibodi
abbrevi
cdr
complementar
determin
region
fdc
follicular
dendrit
cell
phylogenet
tree
antibodi
repertoir
exampl
phylogenet
tree
human
plasmablast
respons
gener
use
cell
barcod
phylogenet
tree
reveal
clonal
famili
guid
express
screen
identifi
antibodi
major
branch
repres
singl
igh
v
j
outer
branch
determin
igl
vj
sequenc
termin
leaf
repres
errorcorrect
fulllength
pair
igh
igl
sequenc
express
individu
b
cell
clonal
famili
colour
code
contain
antibodi
share
igh
vj
igl
vj
sequenc
immunodomin
red
rare
colour
famili
identifi
singl
nucleotid
substitut
substanti
alter
antibodi
bind
specif
affin
order
evalu
spectrum
antibodi
encod
within
clonal
famili
recombin
antibodi
repres
rang
variant
repres
within
famili
express
character
abbrevi
divers
igh
immunoglobulin
heavi
chain
igl
immunoglobulin
light
chain
j
join
rtpcr
revers
transcriptas
polymeras
chain
reaction
v
variabl
tabl
challeng
solut
sequenc
function
antibodi
repertoir
